EBS 最新季度财报
公布日期8/6/2026
实际每股收益(美元)-3.49
实际营收(美元)234.30M
本页面提供详细的 Emergent BioSolutions Inc 财报数据,包括最新财报、下一次财报发布日期、历史数据及 Emergent BioSolutions Inc 财报电话会相关新闻。
| 发布日期 | 报告期末 | 每股收益/预测值 | 营收/预测值 | 每股收益超预期幅度 % | 营收超预期幅度 % |
|---|---|---|---|---|---|
| 8/6/2026 | 06/2026 | -3.49/0.11 | 234.30M/177.50M | -3274.77% | 32.00% |
| 4/30/2026 | 03/2026 | 0.13/-0.25 | 156.10M/145.00M | 152.41% | 7.66% |
| 2/26/2026 | 12/2025 | -1.04/0.11 | 148.70M/217.50M | -1049.07% | -31.63% |
| 10/29/2025 | 09/2025 | 0.96/-0.12 | 231.10M/194.00M | 902.01% | 19.12% |
| 8/7/2025 | 06/2025 | -0.22/-0.49 | 140.90M/146.37M | 54.82% | -3.73% |
| 5/8/2025 | 03/2025 | 1.25/0.44 | 222.20M/219.00M | 184.09% | 1.46% |
| 3/3/2025 | 12/2024 | -0.58/-0.49 | 194.70M/254.67M | -16.66% | -23.55% |
| 11/7/2024 | 09/2024 | 2.16/0.14 | 293.80M/297.50M | 1444.26% | -1.24% |